Journal Home
Login
Register
Open Access Journal
Submit a Paper
Propose a Special lssue
Open Access
ARTICLE
ADVANCED NANOTHERANOSTIC SYSTEMS FOR PRECISION ONCOLOGY AND CARDIOVASCULAR DISEASE MANAGEMENT: MECHANISTIC INSIGHTS, MATERIAL ENGINEERING, AND TRANSLATIONAL PERSPECTIVES
Issue Vol. 2 No. 1 (2025): Volume 02 Issue 01 --- Section Articles
pdf
Abstract
Nanotheranostics has emerged as one of the most transformative paradigms in contemporary biomedical science, integrating diagnostic and therapeutic functionalities within a single nanoscale platform. This convergence responds to the growing demand for precision medicine, where disease detection, treatment, and monitoring are individualized, dynamic, and minimally invasive. The present research article offers an extensive, theory-driven, and integrative analysis of nanotheranostic systems, drawing strictly on the provided body of literature. It explores the conceptual foundations of nanotheranostics, the physicochemical principles governing nanoparticle design, and the biological mechanisms that enable simultaneous imaging and therapy. Particular emphasis is placed on cancer and cardiovascular diseases, which together represent the dominant global disease burden and the primary translational targets of nanotheranostic innovation.
In oncology, nanotheranostics has redefined approaches to tumor imaging, drug delivery, photothermal therapy, photodynamic therapy, and multimodal treatment strategies. Metallic nanoparticles, especially gold-based systems, polymeric carriers, lipid-based nanostructures, and organic fluorescent nanoparticles are examined in depth, with attention to their diagnostic contrast properties, therapeutic payload capacity, surface functionalization, and responsiveness to internal or external stimuli. The Trojan horse strategy and dual-transformable nanoplatforms are analyzed as advanced design concepts that enhance tumor specificity and therapeutic efficacy while minimizing systemic toxicity. The article also critically examines the role of nanotheranostics in oral cancer, melanoma, and other solid tumors, highlighting both preclinical promise and translational challenges.
Beyond oncology, this article extends the discussion to cardiovascular disease, particularly atherosclerosis, where molecular imaging and targeted therapy remain unmet clinical needs. By integrating insights from cardiovascular pathogenesis with nanotheranostic design principles, the article elucidates how nanoparticles can be engineered to target inflammatory processes, lipid accumulation, and plaque instability. The theoretical compatibility between nanotheranostics and cardiovascular precision medicine is explored, emphasizing the potential for early diagnosis, risk stratification, and image-guided intervention.
Methodologically, this work adopts a comprehensive narrative synthesis approach, systematically analyzing the mechanisms, material classes, and biological interactions reported in the referenced literature. The results are presented as a descriptive integration of experimental trends, mechanistic insights, and translational outcomes rather than quantitative meta-analysis. The discussion critically evaluates current limitations, including biocompatibility, long-term toxicity, regulatory barriers, and clinical scalability, while proposing future research directions grounded in materials science, molecular biology, and systems medicine.
In conclusion, this article positions nanotheranostics as a cornerstone of next-generation medicine, capable of unifying diagnosis and therapy across diverse disease contexts. By providing an in-depth, theoretically rich, and publication-ready synthesis, it aims to support researchers, clinicians, and policymakers in advancing nanotheranostic technologies from experimental promise to clinical reality.
Keywords
References
1. Abiodun-Solanke, I., Ajayi, D., Arigbede, A. (2014). Nanotechnology and its application in dentistry. Annals of Medical and Health Sciences Research, 4(Suppl 3), S171–S177.
2. Bjorkegren, J. L. M., Lusis, A. J. (2022). Atherosclerosis: recent developments. Cell, 185(10), 1630–1645.
3. Cabral, R. M., Baptista, P. V. (2014). Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles. Expert Review of Molecular Diagnostics, 14(8), 1041–1052.
4. D’Acunto, M., Cioni, P., Gabellieri, E., Presciuttini, G. (2021). Exploiting gold nanoparticles for diagnosis and cancer treatments. Nanotechnology, 32(19), 192001.
5. Douglas, G., Channon, K. M. (2014). The pathogenesis of atherosclerosis. Medicine, 42(9), 480–484.
6. Eyvazzadeh, N., Shakeri-Zadeh, A., Fekrazad, R., Amini, E., Ghaznavi, H., Kamrava, S. K. (2017). Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer. Lasers in Medical Science, 32(7), 1469–1477.
7. Falk, E. (2006). Pathogenesis of atherosclerosis. Journal of the American College of Cardiology, 47(8), C7–C12.
8. Gao, Q., Zhang, J., Gao, J., Zhang, Z., Zhu, H. (2021). Gold nanoparticles in cancer theranostics. Frontiers in Bioengineering and Biotechnology, 6, 5134–5151.
9. Huang, X., Jain, P. K., El-Sayed, I. H., El-Sayed, M. A. (2008). Plasmonic photothermal therapy using gold nanoparticles. Lasers in Medical Science, 23(3), 217–228.
10. Jin, G., Cheah, P., Qu, J., Liu, L., Zhao, Y. (2020). Applications of nanomaterials for theranostics of melanoma. Journal of Nanotheranostics, 1(1), 39–55.
11. Kim, T., Lee, S., Chen, X. (2013). Nanotheranostics for personalized medicine. Expert Review of Molecular Diagnostics, 13(3), 257–269.
12. Mahesh, K. P. (2018). Nanotheranostics: novel modality for integrating diagnosis and therapy for oral cancer. Acta Scientific Dental Sciences, 2(9), 57–58.
13. Peng, H., Liu, X., Wang, G., Li, M., Bratlie, K. M. (2015). Polymeric multifunctional nanomaterials for theranostics. Journal of Materials Chemistry B, 3(34), 6856–6870.
14. Silva, C., Pinho, J., Lopes, J., Almeida, A., Gaspar, M., Reis, C. (2019). Current trends in cancer nano-theranostics: metallic, polymeric, and lipid-based systems. Pharmaceutics, 11, 22.
15. Wang, L. S., Chuang, M. C., Ho, J. A. (2012). Nanotheranostics: a review of recent publications. International Journal of Nanomedicine, 7, 4679–4695.
16. Xia, Q., Chen, Z., Zhou, Y., Liu, R. (2019). Near-infrared organic fluorescent nanoparticles for long-term monitoring and photodynamic therapy of cancer. Nanotheranostics, 3(2), 156–165.
17. Xue, X., Huang, Y., Bo, R., Jia, B., Wu, H., Yuan, Y., Wang, Z., Ma, Z., Jing, D., Xu, X., Yu, W., Lin, T. Y., Li, Y. (2018). Trojan horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nature Communications, 9(1), 3653.
18. World Health Organization. (2022). Cardiovascular diseases.
